Computational studies of NMDA receptors: differential effects of neuronal activity on efficacy of competitive and noncompetitive antagonists

References

• Berger TW. Long-term potentiation ofhippocampal synaptic transmission affects rate of behavioral learning. Science. 1984;224:627–630.
   PubMed Web of Science ®Google Scholar
• Lynch G, Baudry M. The biochemistry of memory: a new and specific hypothesis. Science. 1984;224:1057–1063.
   PubMed Web of Science ®Google Scholar
• Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51:7–61.
   PubMed Web of Science ®Google Scholar
• Ciabarra AM, et al. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci. 1995;15:6498–6508.
   PubMed Web of Science ®Google Scholar
• Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE. 2004;255:re16.
   Google Scholar
• Kotermanski SE, Johnson JW. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine. J Neurosci. 2009;29:2774–2779.
   PubMed Web of Science ®Google Scholar
• Morris RG. Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci. 1989;9:3040–3057.
   PubMed Web of Science ®Google Scholar
• Santucci DM, Raghavachari S. The effects of NR2 subunit-dependent NMDA receptor kinetics on synaptic transmission and CaMKII activation. PLoS Comput Biol. 2008;4:e1000208.
   PubMed Web of Science ®Google Scholar
• Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int J Geriatr Psychiatry. 2003;18:S23-S32.
   PubMed Web of Science ®Google Scholar
• Rammes G, Danysz W, Parsons CG. Pharmacodynamics of memantine: an update. Curr Neuropharmacol. 2008;6:55–78.
   PubMed Web of Science ®Google Scholar
• Schorge S, Elenes S, Colquhoun D. Maximum likelihood fitting of single channel NMDA activity with a mechanism composed of independent dimers of subunits. J Physiol. 2005;569:395–418.
   Web of Science ®Google Scholar
• Liu L, et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science. 2004;304:1021–1024.
   PubMed Web of Science ®Google Scholar
• Bouteiller JM, et al. Modeling glutamatergic synapses: insights into mechanisms regulating synaptic efficacy. J Integr Neurosci. 2008;7:185–197.
   Google Scholar
• Hucka M, et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics. 2003;19:524–531.
   PubMed Web of Science ®Google Scholar
• Jahr CE, Stevens CF. Voltage dependence of NMDA-activated macroscopic conductances predicted by single-channel kinetics. J Neurosci. 1990;10:3178–3182.
   PubMed Web of Science ®Google Scholar
• Wyllie DJ, Johnston AR, Lipscombe D, Chen PE. Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit. J Physiol. 2006;574:477–489.
   Web of Science ®Google Scholar
• Ascher P, Nowak L. The role of divalent cations in the N-methyl- D-aspartate responses of mouse central neurones in culture. J Physiol. 1988;399:247–266.
   PubMed Web of Science ®Google Scholar
• Zhang W, Howe JR, Popescu GK. Distinct gating modes determine the biphasic relaxation of NMDA receptor currents. Nat Neurosci. 2008;11:1373–1375.
   Web of Science ®Google Scholar
• Frizelle PA, Chen PE, Wyllie DJ. Equilibrium constants for (R)-[(S)- 1 -(4-bromo-phenyl)-ethylamino] -(2,3 -dioxo-1,2,3,4-tetrahydroquino xalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. Mol Pharmacol. 2006;70:1022–1032.
   PubMed Web of Science ®Google Scholar
• Anson LC, Schoepfer R, Colquhoun D, Wyllie DJ. Single-channel analysis of an NMDA receptor possessing a mutation in the region of the glutamate binding site. J Physiol. 2000;527 Pt 2:225–237.
   Google Scholar
• Benveniste M, Mienville JM, Sernagor E, Mayer ML. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons. J Neurophysiol. 1990;63:1373–1384.
   Web of Science ®Google Scholar
• Popescu G, Robert A, Howe JR, Auerbach A. Reaction mechanism determines NMDA receptor response to repetitive stimulation. Nature. 2004;430:790–793.
   Web of Science ®Google Scholar
• Fayyazuddin A, Villarroel A, Le Goff A, Lerma J, Neyton J. Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors. Neuron. 2000;25:683–694.
   PubMed Web of Science ®Google Scholar
• Gielen M, et al. Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition. Neuron. 2008;57:80–93.
   PubMed Web of Science ®Google Scholar
• Madry C, Mesic I, Betz H, Laube B. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors. Mol Pharmacol. 2007;72:1535–1544.
   Web of Science ®Google Scholar
• Erreger K, Traynelis SF. Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. J Physiol. 2005;569:381–393.
   PubMed Web of Science ®Google Scholar
• Kloda A, Clements JD, Lewis RJ, Adams DJ. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. Mol Pharmacol. 2004;65:1386–1396.
   Web of Science ®Google Scholar
• Collingridge G. Synaptic plasticity. The role of NMDA receptors in learning and memory. Nature. 1987;330:604–605.
   PubMed Web of Science ®Google Scholar
• Grover LM, Kim E, Cooke JD, Holmes WR. LTP in hippocampal area CA1 is induced by burst stimulation over a broad frequency range centered around delta. Learn Mem. 2009;16:69–81.
   Web of Science ®Google Scholar
• Farin A, Marshall LF. Lessons from epidemiologic studies in clinical trials of traumatic brain injury. Acta Neurochir. 2004;Suppl 89:101–107.
   Google Scholar
• Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984;43:1369–1374.
   PubMed Web of Science ®Google Scholar
• Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383–386.
   PubMed Web of Science ®Google Scholar
• Davis SM, et al. Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke. 2000;31:347–354.
   PubMed Web of Science ®Google Scholar
• Parsons CG, Stoffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology. 2007;53;699–723.
   Google Scholar
• Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov. 2006;5:160–170.
   PubMed Web of Science ®Google Scholar
• Urakubo H, Honda M, Froemke RC, Kuroda S. Requirement of an allosteric kinetics of NMDA receptors for spike timing-dependent plasticity. J Neurosci. 2008;28:3310–3323.
   PubMed Web of Science ®Google Scholar
• Harrision NL, Simmonds MA. Quantitative studies on some antagonists of N-methyl-D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985;84:381–391.
   Web of Science ®Google Scholar